Epirubicin
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8098 publications
Nitrogen doped carbon dots with antibacterial activity for dual mode fluorescence and smartphone-assisted colorimetric detection of epirubicin.
Journal: Analytical methods : advancing methods and applications
Published: April 07, 2026
Clinical and Radiological Outcomes Comparison of Degradable Starch Microspheres TACE with Idarubicin vs. Epirubicin Protocol in Patients with HCC.
Journal: Diagnostics (Basel, Switzerland)
Published: March 11, 2026
Effective Management of Chemotherapy-Induced Cardiotoxicity: A Prospective Follow-Up Study on Alternative Regimens in Bangladeshi Cancer Patients.
Journal: Cureus
Published: March 07, 2026
Expression of Concern: ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance.
Journal: Molecular cancer therapeutics
Published: February 05, 2026
Sequential and synergistic delivery of lipiodol and drug-eluting microspheres circumvents incompatibility to enhance targeted chemoembolization.
Journal: Frontiers in pharmacology
Published: January 31, 2026
A Case Study of Severe Myelosuppression Induced by Adjuvant Chemotherapy in a Breast Cancer Patient with Concurrent Immune Thrombocytopenia(ITP)
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026
Expression of Concern: The p38 MAPK-MK2 Axis Regulates E2F1 and FOXM1 Expression after Epirubicin Treatment.
Journal: Molecular cancer research : MCR
Published: January 16, 2026
Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT.
Journal: Breast care (Basel, Switzerland)
Published: January 09, 2026
Multi-agent chemotherapy for refractory head and neck cancer.
Journal: Journal of the Chinese Medical Association : JCMA
Published: January 08, 2026
International Guideline Harmonization Group Recommendations for Breast Cancer Surveillance in Childhood, Adolescent, and Young Adult Cancer Survivors After Anthracyclines.
Journal: JCO oncology practice
Published: January 07, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-line treatment for patients with Undifferentiated Pleomorphic Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 05, 2026
Ewing Sarcoma of the Maxilla: An Uncommon Anatomical Presentation in a Young Patient.
Journal: Cureus
Published: December 25, 2025
Last Updated: 04/28/2026